Banque Pictet & Cie Sa Vertex Pharmaceuticals Inc Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

A detailed history of Banque Pictet & Cie Sa transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 11,255 shares of VRTX stock, worth $4.61 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,255

Previous 25,264 55.45%

Holding current value

$4.61 Million

Previous $11.8 Million 55.8%

% of portfolio

0.04%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$460.0 - $505.78 $6.44 Million - $7.09 Million	-14,009 Reduced 55.45%	11,255 $5.23 Million
Q2 2024 Jul 25, 2024	BUY	$392.81 - $485.53 $1.19 Million - $1.47 Million	3,024 Added 13.6%	25,264 $11.8 Million
Q1 2024 May 06, 2024	SELL	$407.69 - $446.08 $395,459 - $432,697	-970 Reduced 4.18%	22,240 $9.3 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $1.15 Million - $1.38 Million	-3,354 Reduced 12.63%	23,210 $9.44 Million
Q3 2023 Nov 02, 2023	SELL	$338.18 - $362.46 $526,884 - $564,712	-1,558 Reduced 5.54%	26,564 $9.24 Million
Q2 2023 Aug 04, 2023	BUY	$314.42 - $351.91 $382,020 - $427,570	1,215 Added 4.52%	28,122 $9.9 Million
Q1 2023 May 01, 2023	BUY	$283.23 - $323.1 $747,443 - $852,660	2,639 Added 10.87%	26,907 $8.48 Million
Q4 2022 Feb 06, 2023	SELL	$285.76 - $321.48 $6.37 Million - $7.16 Million	-22,285 Reduced 47.87%	24,268 $0
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $3.87 Million - $4.32 Million	-14,145 Reduced 23.3%	46,553 $13.5 Billion
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $5.85 Million - $7.28 Million	-24,898 Reduced 29.09%	60,698 $17.1 Million
Q1 2022 May 04, 2022	SELL	$221.42 - $260.97 $1.53 Million - $1.8 Million	-6,905 Reduced 7.46%	85,596 $22.3 Million
Q4 2021 Feb 02, 2022	BUY	$177.01 - $223.45 $10.2 Million - $12.9 Million	57,611 Added 165.12%	92,501 $20.3 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $177,762 - $198,930	980 Added 2.89%	34,890 $6.33 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $1.27 Million - $1.5 Million	-6,762 Reduced 16.63%	33,910 $6.84 Million
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $301,421 - $351,347	1,456 Added 3.71%	40,672 $8.74 Million
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $7.67 Million - $10.2 Million	37,055 Added 1714.72%	39,216 $9.27 Million
Q3 2020 Nov 10, 2020	BUY	$255.65 - $303.1 $80,785 - $95,779	316 Added 17.13%	2,161 $588,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $31,567 - $41,412	140 Added 8.21%	1,845 $536,000
Q1 2019 May 02, 2019	SELL	$163.73 - $194.7 $91,688 - $109,032	-560 Reduced 24.72%	1,705 $314,000
Q4 2018 Jan 31, 2019	SELL	$151.91 - $192.21 $142,795 - $180,677	-940 Reduced 29.33%	2,265 $375,000
Q3 2018 Nov 07, 2018	BUY	$167.73 - $192.74 $251,594 - $289,110	1,500 Added 87.98%	3,205 $618,000
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $258,478 - $302,006	1,705 New	1,705 $278,000

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Vertex Pharmaceuticals Inc Transaction History